Current Issue Mar-Apr 2023; Volume 3, Issue 2
ISSUE HIGHLIGHTS
Purchase access
Email Alerts
Table of contents Mar-Apr 2023; Volume 3, Issue 2
Review articles
Primary Testicular Lymphoma: Single Center Experience
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
139-144
DOI: 10.21873/cdp.10192
An Update on Clinicopathological, Imaging, and Genetic Features of Angioleiomyoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
145-150
DOI: 10.21873/cdp.10193
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
151-156
DOI: 10.21873/cdp.10194
Metachronous Single Pulmonary Metastasis of Prostate Cancer: Report of a Rare Case and Literature Review
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
157-162
DOI: 10.21873/cdp.10195
Iron Deficiency Anemia in Colorectal Cancer Patients: Is Preoperative Intravenous Iron Infusion Indicated? A Narrative Review of the Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
163-168
DOI: 10.21873/cdp.10196
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
169-174
DOI: 10.21873/cdp.10197
Research articles
Pharmacodynamic Modeling Identifies Synergistic Interaction Between Chloroquine and Trastuzumab in Refractory HER2- positive Breast Cancer Cells
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
175-182
DOI: 10.21873/cdp.10198
Effects of siRNA-mediated Silencing of ERBB2, IGF-1R, and ITGB1 in HER2-positive Breast Cancer Cells
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
183-188
DOI: 10.21873/cdp.10199
Impact of CD34-dependent Micro Vessel Density on Periapical Odontogenic Cysts
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
189-193
DOI: 10.21873/cdp.10200
Clinical Outcomes and Toxicity of CT-guided High Dose-rate Brachytherapy in Women With Locally-advanced Cervical Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
194-200
DOI: 10.21873/cdp.10201
Clinical Outcomes of Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
201-207
DOI: 10.21873/cdp.10202
Perineural Invasion Predicts Unfavorable Prognosis in Patients With Invasive Breast Cancer
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
208-214
DOI: 10.21873/cdp.10203
NSCLC Patients Achieving Long-term Progression-free Survival With Docetaxel Plus Ramucirumab: A Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
215-220
DOI: 10.21873/cdp.10204
Long-term Prognostic Impact of Metachronous Rectal Cancer in Patients With Familial Adenomatous Polyposis: A Single-center Retrospective Study
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
221-229
DOI: 10.21873/cdp.10205
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
230-235
DOI: 10.21873/cdp.10206
Does Pathological T-Factor Affect Long-term Prognosis of Locally Advanced Colorectal Cancer Treated With Laparoscopic Multivisceral Resection?
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
236-243
DOI: 10.21873/cdp.10207
Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
244-250
DOI: 10.21873/cdp.10208
Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
251-256
DOI: 10.21873/cdp.10209
Palliative Radiotherapy Induced Severe Tumor Lysis Syndrome in a Patient With Multiple Myeloma With Skin Involvement: A Case Report and Review of Literature
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
257-263
DOI: 10.21873/cdp.10210
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Cancer Diagnosis & Prognosis
Mar-Apr;
3(2):
264-271
DOI: 10.21873/cdp.10211